FILTER
LATEST INTERVIEWS
Dato’ Muhtar Hashim
EXECUTIVE DIRECTOR, CHEMICAL INDUSTRIES COUNCIL OF MALAYSIA (CICM)
“The challenge for the Malaysian chemical industry is different: We must question where we go from here onwards and push forward into the specialty space.”
NJ Ayuk
EXECUTIVE CHAIRMAN, AFRICAN ENERGY CHAMBER
"We are combating the demonization of natural gas usage, emphasizing Africa's right to utilize it for development."
Ajay Tandon
CEO, VEEDA CLINICAL RESEARCH LIMITED
"Although the US may have been ahead in technology adoption initially, India has been catching up rapidly."
Kati McCartney
PRESIDENT, FROSKR
"Mining’s social license to operate hinges on access to and utilization of data."
Davaatseren Badamdorj
FOUNDER & CEO, GREEN CHEMISTRY
"I see Green Chemistry becoming a one-stop-shop solution for everything chemicals-related."
Jonathan Cain
MANAGING DIRECTOR, MMD GREEN MINING SOLUTIONS (MAURITIUS)
"In the context of conducting business in Mongolia, knowledge dissemination has played a pivotal role."
Andrew Brodkey
COO, IDAHO COPPER
"CuMo is among the largest undeveloped copper projects in the Americas, and likely the largest undeveloped molybdenum project in the world."
Dan Weir
CO-FOUNDER AND CEO, COPPER BULLET MINES
"The Copper Springs project is approximately 9,000 acres. We plan to stake additional land to grow our property significantly. Fortunately, we have a historical open pit resource of approximately 47 million t at about 0.4% copper."
Sergio Aburto
DIRECTOR LATIN AMERICA NORTH, ACADIAN PLANT HEALTH
"We harvest our Ascophyllum nodosum manually to maintain the seaweed beds, as machine-harvesting may damage the seaweed."
Sergio Chiñas
CEO, FIRST QUALITY CHEMICALS
"I want to preserve the fantastic work culture that we have built here over the years. Keeping this culture intact would be our priority in any M&A deal."
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENT PUBLICATIONS
United States Life Sciences 2025 - Digital Interactive
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
Resilience amid uncertainty. These words encapsulate the US life sciences sector as it navigates 2025. While the industry has largely rebounded from the recent biotech bear market, with clinical trial starts and funding showing signs of rebound, headwinds remain.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
